IDEA-FAST General Assembly 2024 – Desenzano del Garda

On March 12th-13th, in Desenzano del Garda, the IDEA-FAST consortium gathered to discuss current progress and next steps during the 2024 General Assembly. More than 100 participants from over 50 partner organizations took part in the sessions, in person and online, including participants in our Clinical Observational Study (COS). The assembly included sessions that enabled […]

ECCO Congress – Chris Lamb Presentation

Dr. Chris Lamb of Newcastle University was a keynote speaker during the ECCO European Crohn’ and Colitis Organisation Congress held on February 21st -24th in Stockholm. His plenary talk with Cate Titterton focused on the similarities and differences between patient and clinician endpoints in therapy.

New Partners Join IDEA-FAST Consortium

We are excited to announce two new partners have officially joined the IDEA-FAST consortium. Bristol-Myers Squibb and University College Cork have commenced their activities in the project during the last quarter of 2023.  Bristol-Myers Squibb (BMS) is a global pharma company with the mission to discover, develop and deliver innovative medicines for an array of […]

Project Milestone – 1000 Clinical Observation Study Participants

We’re thrilled to share a significant milestone in our journey – the recruitment of the 1000th participant in our IDEA-FAST Clinical Observation Study (COS)!  This marks a monumental achievement as we hit four digits for the first time and reach halfway to our ambitious target of 2000 participants. Achieving this milestone is a reflection of […]

IDEA-FAST Highlighted as an Excellent Innovation by Innovation Radar

We are proud to announce that IDEA-FAST has been highlighted in the European Commission Innovation Radar. Three of our Innovations have been evaluated as excellent by the European Commission. Our main innovations encompass: New digital biomarkers for clinical trials in neurodegeneration and immune-inflammatory disorders Digital multi source dataset-biobank for the development of digital biomarkers Data […]

IDEA-FAST Newsletter – September 2023

We are proud to announce the IDEA-FAST September Newsletter is here! Find out about recent events, publications, and IDEA-FAST partners, as well as upcoming IDEA-FAST activities. We would like to say a big thank you to all IDEA-FAST partners for their contribution and dedication to the project. Read the full newsletter on our page.

New Paper on Regulatory Qualifications of Digital Measures

Check out our new paper! The article reviews IDEA-FAST’s efforts to develop digital measures of fatigue and sleep disturbances for multiple diseases, and the advice provided by the European Medicines Agency on its plans for regulatory qualification of the proposed measures. The insights included in this paper can serve as a guide in the development […]

New Cambridge Cognition Blog Post on Partnership with IDEA-FAST

Patients with debilitating fatigue know they can often be left feeling ignored and maligned. While fatigue is surprisingly common across many neurodegenerative and inflammatory conditions, there is still widespread scepticism that the condition exists. In this article, Dr Michele Veldsman, Director of Neuroscience at Cambridge Cognition explores IDEA-FAST’s efforts towards quantifying and conquering fatigue. Read […]

Reminder: TMF and Lygature Workshop

From BITS to BETTER Reminder: Register now for the workshop on meaningful patient involvement in developing digital endpoints in research and disease management  22 September 2023, 12.30-17.00 o’clock, Beatrixgebouw (Jaarbeurs), Utrecht (NL) or online. In cooperation with TMF. UPDATE: Due to high demand and our wish to accommodate people living with reduced ability to travel […]